Clinicopathological correlation analysis showed that hsa-miR-623 expression was significantly correlated with tumor differentiation, smoking history, lymphatic metastasis and elevated serum CEA level in patients with lung adenocarcinoma, which was similar to the results found in the study of Ku80. This evidence concerns the gene CEACAM5 and lung adenocarcinoma.